Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study with 506 Patients, Followed-Up a Median of 9 Years

By  

Current HIV Research, Vol. 10, Iss. 6, 2012-09 ,pp. : 513-520

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy

By Hosokawa Ayumu   Sugiyama Toshiro   Ohtsu Atsushi   Doi Toshihiko   Hattori Santa   Kojima Takashi   Yano Tomonori   Minashi Keiko   Muto Manabu   Yoshida Shigeaki  

Journal of Gastroenterology, Vol. 42, Iss. 7, 2007-07 ,pp. : 533-538

Springer Publishing Company

Access to resources Recommend Favorite

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability

By Préau M.   Protopopescu C.   Raffi F.   Rey D.   Chêne G.   Marcellin F.   Perronne C.   Ragnaud J.M.   Leport C.   Spire B.    

AIDS Care, Vol. 24, Iss. 4, 2012-04 ,pp. : 434-443

Routledge Ltd

Access to resources Recommend Favorite

Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients

By  

Current HIV Research, Vol. 12, Iss. 5, 2014-09 ,pp. : 339-346

Bentham Science Publishers

Access to resources Recommend Favorite

Cytotoxic T lymphocyte responses in HIV-1-infected long-term nonprogressors: lessons for vaccine design

By Navis Marjon   Miedema Frank   Schuitemaker Hanneke  

Future HIV Therapy, Vol. 2, Iss. 4, 2008-07 ,pp. : 351-361

Future Medicine

Access to resources Recommend Favorite